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Abstract
Ferric Iron Nanoparticle Formation Mediated By
Negatively Charged Polypeptides
Vamsi Krishna Aluru
The creation of magnetite particles by magnetotactic bacteria has been of great interest for a
number of years. Previous studies have shown that magnetite nanocrystals have been synthesized
in the presence of recombinant Mms6 protein. Mms6 plays a vital role in the biomineralization
of bacterial magnetite nanocrystals. The objective of this research is to determine the effect of
functional group type on size and shape of magnetic nanoparticles formed by biomineralization.
Control over the size of nanoparticles is paramount. Use of nanoparticles as contrast agents in
MRI is advantageous, as they are small enough to be localized in desired region by applying
local magnetic fields. Sequences VA-Mms6, VA1, VA2, and VA3 were designed with
modifications in the functional groups Mms6 sequence. Solutions of peptide were mixed with
ferric and ferro salts and allowed to interact under inert atmosphere. The nanoparticles formed
are examined under SEM and TEM and compared for differences. The SEM and TEM images of
nanoparticles produced with the aid of the above peptides had similarity to those produced in the
magnetotactic bacteria. However, discrete particles with a narrower size range were produced
using the peptide VA2. XPS, AFM, DLS and MFM were also done on the synthesized
nanoparticles. The results were in good agreement when compared to those with a standard
control sample of magnetite nanoparticles. Use of peptides with different functional groups may
provide a unique route to produce uniform magnetite nanocrystals with definite control of
morphology.
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Chapter 1

Introduction
1.1 Biopolymers
A biopolymer is formed via a biological route using sugars, amino acids or nucleotides as the
building blocks. A few examples of biopolymers are cellulose, proteins and DNA. Genetically
directed biosynthetic routes for producing protein-based polymers allow controlled spatial
arrangement of macromolecules. Secondary structures and charges on the macromolecules can
be controlled precisely through biosynthetic routes.
Protein folding, which plays a vital role in the functioning of proteins, can be controlled by
monitoring amino acid sequence. Materials that have similar properties can be produced by
mimicking naturally produced protein fibers such as silk, elastin and collagen. A specified
polymer sequence is produced with high dependability when a gene encoding a target protein is
translated into the protein sequence at the ribosome.1 Production of a polymer sequence is a two
step process as shown in Figure 1. First, a particular DNA sequence is converted into a
corresponding messenger RNA (mRNA) sequence. This step is known as transcription. The
mRNA sequence serves as a template for protein synthesis. Decoding of mRNA is known as
translation. Transfer RNA (tRNA) molecules play a central role in translation step. tRNA serves
as a physical link between the mRNA and the growing polypeptide, and an informational link,
ensuring that the polypeptide being synthesized has the proper amino acid sequence encoded by
the mRNA.

1

Figure 1: Schematic diagram of protein synthesis

1.2 Examples of Biopolymers
Silk is obtained from either silkworms or spiders and is one of the strongest natural protein fibers
available. Because of the good mechanical and functional properties, silk is useful for biomedical
applications. Silk fibroin from domestic silkworm Bombyx mori (B.mori) is used in medicine as
sutures and artificial ligaments.2 For centuries, silk fibers have been used as sutures for wounds
owing to their biocompatibility, low immunogenicity and high strength. Silk fibroins extracted
from B.mori are spun from aqueous solution and have been used as a scaffold for human aortic
endothelial cells and human coronary artery smooth muscle cells. In both cases, vascular tissues
were formed in one week.3 Though silk is used extensively in many biomedical applications, the
biggest obstacle is the production of silk in large quantities because of the dependence on spiders
and silkworms to produce the material. Thus, a biomimetic approach has been used in which
amino acid sequences from silk are used to produce silk-mimetic artificial proteins using genetic
methods.2 Many attempts to design polymers similar to those of naturally occurring silks have
been focused on silk protein sequences from B.mori silkworm and samia Cynthia ricini
silkworm. The polyalanine and alanine-rich segments in the proteins from both spiders and
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silkworms are thought to play a vital role in the mechanical properties of silks.2 These silk
proteins are mimicked and expressed in host cells like yeast to yield silk like materials.
Elastin is a protein that allows many tissues in body to return to their original shape after
expansion. The main component of elastin is hydrophobic domain which contains valine and
glycine in large quantity.2 The repeated sequence VPGVG mediates the mechanical properties of
the protein and variations in this sequence have been used to produce elastin-like protein
polymers.2 Elastin-like polypeptides (ELPs) exhibit an inverse temperature phase transition.
Below their transition temperature ELPs are soluble in aqueous solutions; however, the proteins
collapse through hydrophobic interactions at temperatures greater than the transition
temperature. Elastin-like polypeptides (ELPs) are used in drug delivery systems. Elastin-like
polypeptides (ELPs) coupled to drugs ,which exhibit a transition temperature between body
temperature and the temperature in a locally heated region, can effectively be used in treatment
of solid tumours.4
The above example shows the use of genetically directed techniques to produce protein-based
materials. Similarly, these techniques can be extended further to produce molecules that mimic
proteins involved in the formation of nanoparticles in magnetotactic bacteria. To understand the
mechanism of magnetite formation in bacteria, several proteins tightly bound to bacterial
magnetite proteins in M. magneticum AMB-1 were isolated by Arakaki and co.5 They used these
proteins to nucleate the formation of magnetite extracellularly.

1.3 Synthesis of Iron Nanoparticles via chemical routes
Iron particles can be synthesized using chemical and biological routes. The following are a few
examples of chemical routes to synthesize iron nanoparticles.
1.3.1 Co-precipitation
Crystalline iron particles can be synthesized from aqueous Fe2+/Fe3+ salt solutions by the
addition of a base in inert atmosphere.6 The mean size of particles can be controlled by adjusting
3

the pH and ionic strength of the precipitation medium. As the pH and ionic strength of medium
increases, size of the particles decreases.7 The chemical composition of the surface and the
electrostatic surface charge of the particles are influenced by pH and ionic strength of medium.
In this method, it is possible to control the mean size of particles between 2nm to 15nm. Owing
to the huge surface-area to volume ratio, nanoparticles produced by co-precipitation tend to
aggregate in solution in order to reduce their surface energy.8
1.3.2 Thermal Decomposition
Thermal decomposition of organometallic compounds (metal acetylacetonate, where the metals
can be Fe, Mn ,Co, Ni or Cr), in the presence of surfactants results in formation of magnetic
nanocrystals.9 The control over the size and morphology of the particles depends upon the initial
ratio between organometallic compounds, surfactants and solvent. Based on the pyrolysis of
metal fatty acids (decanoic acid, lauric acid, myristic acid, palmic acid, oleic acid, stearic acid) in
non-aqueous solutions, a decomposition method was followed by Peng and co-workers to
synthesize magnetic oxide nanocrystals.10 Fe3O4 nanocrystals over a size range of 3-50 nm were
synthesized. Variation in the reactivity and concentration of the precursors can be used to control
the size and morphology of nanocrystals. The reactivity was adjusted by changing the chain
length and concentration of fatty acids; the shorter the chain length, the faster is the reaction rate.
Hyeon and co-workers used nontoxic iron (III) chloride and sodium oleate to prepare
monodisperse iron oxide nanoparticles.11 Depending on the decomposition temperature, particle
sizes over a range of 5nm-22nm were formed. The nanoparticles formed by this method were
dispersible in organic solvents, but in most biomedical applications water dispersible magnetic
particles are desirable.9 One of the disadvantages to thermal decomposition is the time
consuming and complicated process.
1.3.3 Two phase method (Microemulsion)
In order to obtain metal oxide nanoparticles, microemulsions such as water in oil are being
investigated. A microemulsion is a thermodynamically stable isotropic dispersion of two
immiscible liquids, where an interfacial film stabilizes the microdomain of one or both liquids.12
4

These microemulsions coupled with surfactants offers a distinct environment for the growth of
nanoparticles.9 Carpenter et al. prepared metallic iron particles coated by a thin layer of gold. 13
Coating protects the iron core from oxidation, making them applicable in biomedicine. The
nanoparticles formed via microemulsion methods are difficult to scale-up and the properties of
the particles are adversely affected by the residual surfactants. Nanoparticles synthesized by this
method have particle sizes which vary over a wide range; moreover the yield of nanoparticles is
very low when compared to thermal decomposition and co-precipitation. Synthesis of
nanoparticles at industrial level requires high temperatures, pH, and pressures and results in
formation of toxic byproducts. Table 1 gives an overall comparison of the synthetic methods
used for synthesis of nanoparticles.
Table 19: Comparison of Synthetic Methods

Synthetic Method

Co-Precipitation

Thermal deposition

Microemulsion

Synthesis
Very simple, ambient
conditions
Complicated,

inert

atmosphere
Complicated, ambient
conditions

Reaction

Reaction

Shape

Temp [°C]

Period

Control

20-90

Minutes

Not good

High

Very good

High

Good

Low

100-320

20-50

Hoursdays
Hours

Yield

1.4 Biomineralization
Because of the high temperature and time often required to make nanoparticles,
biomineralization is a new technique being investigated. Biomineralization refers to processes by
which organisms make minerals. Until the early 1980s biomineralization was known as
“calcification” due to the predominance of biologically formed calcium-containing minerals.
Over a period of time, many more biogenic minerals were discovered and a more specific term
“biomineralization”, was given. A high degree of control is exerted by organisms over mineral
formation in biomineralization. A few examples of biominerals are carbonates, phosphates,
oxides, and fluorides.14,15 Biomineralization processes can be classified into two groups based on
5

their degree of biological control. In the 1980‟s Lowenstam introduced these processes as
“biologically induced mineralization” (BIM) and “biologically controlled mineralization”
(BCM). There is a marked difference between the two processes in terms of the functionality of
the biomineralized particles. Particles that are produced by BIM have no function except that
they might act as a form of protection from different environments, whereas particles produced
by BCM have high degree of crystallinity. Particles formed by BCM have definite shape and size
which makes them useful in many biomedical applications. One of the best examples of BCM is
the formation of magnetic nanoparticles in magnetosomes within the magnetotactic bacteria.
Biomineralization of magnetite has also been found in algae,16 insects,17 birds and even
humans.18

1.5 Magnetotactic Bacteria
Magnetotactic bacteria are aquatic prokaryotes that can move under the direction of a local
geomagnetic field. The term magnetotactic bacteria, was first cited in a publication in 1963
written by Salvatore Bellini. R.P. Blakemore observed that under the influence of a magnetic
field, bacteria migrated from south to north, giving rise to the term magnetotactic.19 This
behavior is attributed to the existence of cytoplasmic membrane vesicles termed „magnetosomes‟
which enclosed magnetite particles of uniform morphology.19 Different strains of magnetic
bacteria show different migration patterns under local geomagnetic fields. Magnetic bacteria
discovered in Northern Hemisphere migrate parallel to the magnetic field, show a northward
migration under the influence of geomagnetic field , and are termed north-seeking (NS)
magnetotactic bacteria.19 Magnetotactic bacteria discovered in southern hemisphere migrate antiparallel to the local geomagnetic fields, show a southward migration in the geomagnetic field ,
and are termed south-seeking magnetotactic bacteria.20 The magnetotactic bacteria discovered
near equator were equally distributed south-seeking and north-seeking bacteria.21
After the discovery of the first magnetotactic bacterial strain, there were reports of magnetotactic
bacterial strains from marine and fresh water.22,23,24 Magnetotactic bacteria have different cellular
morphologies; they can be cocoid, rod-shaped, helical or multicellular”.22,25 Despite their
diversity in cellular morphologies, several features are common in all strains. All magnetotactic
6

bacteria possess magnetosomes and are motile. Magnetotactic bacteria are very sensitive to
environmental oxygen concentration and most of them can only synthesize magnetosomes in
very low oxygen concentrations.26 All magnetotactic bacteria reported to date are gram-negative
bacteria. Gram-negative bacteria are those which do not retain the crystal violent dye in gram in
the gram staining protocol.
Magnetotactic bacteria discovered to this point fall into one of the following categories:
microaerophiles, anaerobic or both.25 In aqueous environments magnetotactic bacteria are found
in great numbers in an oxic-anoxic transition zone (OATZ). Magnetotactic bacteria can
synthesize magnetosomes only if low oxygen concentrations are present. In general, if the initial
oxygen concentration in the atmosphere of cultures is higher than 6%, these bacteria cannot
synthesize magnetite.23
1.5.1 Bacterial Magnetite Particles
Magnetotactic bacteria produce two types of minerals; iron oxides and iron sulfides. The type of
mineral biomineralized is dependent on the external environment in which bacteria survive. The
magnetotactic bacteria that produce iron oxides biomineralize magnetite (Fe3O4) and those that
produce iron sulfides biomineralize greigite (Fe2+Fe3+2S4) and sometimes pyrites (FeS2).27
Magnetite is found in bacteria from microaerobic fresh water and marine environments, whereas
greigite is found in bacteria from marine environments only. First direct evidence of magnetite
was found in 1979 by R.P.Blakemore when he isolated the first pure culture of magnetotactic
bacteria, Magnetotactic Spirillium strain MS-1.23 With the help of Mossbauer spectroscopy,
Frankel et al. concluded that the iron containing mineral present was Fe3O4 .Magnetite particles
so synthesized had high chemical purity and had an average size of 50nm.24 Some magnetotactic
bacteria synthesize both magnetite and greigite.25
All magnetosomes are of size 35-120nm regardless of their composition. The morphologies of
the crystals reported to date fall into three categories; cuboidal, elongated prismatic and tooth-,
bullet-or arrowhead-shaped.25 Particles of size range 35-120nm formed stable single magnetic
domain (SMD) particles. The magnetic moment is the net sum of moments of individual crystals
7

in the chain. Magnetite particles within SMD range are permanently magnetic and their magnetic
moment remains stable under ambient conditions.28 Particles whose size is less than 35 nm tend
to be super paramagnetic and their net moment approaches zero. Particles with size greater than
120 nm are non-uniformly magnetized as multiple magnetic domains are formed. The
magnetostatic interactions between particles results in the formation of a permanent magnetic
dipole. A cell requires twenty 50nm magnetosomes to have sufficient magnetic dipole moment
for orientation along geomagnetic field.26 The magnetite particles which are synthesized are
aligned in chains ,and these chains act as compass needles and help in migration of
magnetotactic bacteria.25
Synthesis of bacterial magnetosomes is a multistep process and involves - 1) magnetosome
vesicle formation 2) iron uptake into the cell and then into the magnetosome vesicle and 3)
magnetite or greigite biomineralization.5 Synthesis of magnetite particles involves three stages:
First, ferric ions are taken up by the cell through a specific iron transport and then reduced to
ferrous ions and transported into magnetosome vesicles. Second, ferrous ions are reoxidized to
ferric ions and form hydrous ferric oxides. Third, one-third of ferric ions in ferric oxides are
reduced into ferrous ions forming magnetite particles with defined morphology.

29,25

Different

strains adopt different routes to transport iron into vesicles. In the Magnetospirillum Magneticum
strain AMB-1, iron is transported in the form of Fe (II).30 Figure 2 shows the schematic
mechanism of iron uptake in Magnetospirillum Magneticum strain AMB-1.

Fe2+

Fe3+

Cell Wall

-e-

Fe2+

Fe2+

Vesicle

Reduction
Magnetite crystals
Cytoplasm

Figure 2: Schematic diagram of iron uptake mechanism in Magnetospirillum Magneticum strain AMB-1
(FRAMES 1-4)

First iron is reduced from ferric to ferrous at cell wall. Next, Fe+2 is transported to cytoplasm
(Frame2) and then into vesicle (Frame 3) where it is finally oxidized to form magnetite particles
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(Frame 4). In Magnetospirillum Magneticum strain MS-1 Fe (II) is transported with the aid of
siderophores.31 In the Magnetospirillum gryphiswaldense strain, MSR-1, iron is taken in the
form of Fe (III) without the aid of siderophores.25, 32
1.5.2 Magnetosome
Magnetosomes are cell organelles with the magnetite crystal inside and an outer cover of a lipid
bilayer membrane. The membrane is made up of phospholipids and has a similar composition as
the cytoplasmic membrane.28,25, 33 The term „magnetosome‟ was first used by Balkwill et al. to
describe “the electron-dense particles and their associated bounding layers in magnetotactic
bacteria”.33 Individual magnetosomes are linked to form chains, and they are attached to inner
cytoplasmic membrane of the cell.
In 1988, Gorby et al. characterized the magnetosome membrane for the first time.34 The
components of magnetosome membrane are mainly phospholipids, fatty acids and some proteins
that were similar to those observed in cytoplasmic membrane. Although the composition of a
magnetosome membrane is similar to cytoplasmic membrane, there was no clear evidence of the
formation of magnetosome until 2006.35

In 2004, Komeili et al. showed the existence of

magnetosome vesicles prior to magnetite formation in Magnetospirillum magneticum strain
AMB-1, and protein MamA was required for their activation.36 Deletion of the mama gene, a
gene encoding MamA, resulted in shorter magnetosome chains being synthesized inside the
cells. Komeili proposed two possible functions of the protein MamA in magnetosome formation:
1) it may be involved in magnetosome assembly, 2) it may be used by magnetotactic bacteria to
control the number of magnetosome vesicles they synthesize. In 2007, Komeili et al. studied the
molecular mechanism of magnetosome formation in Magnetospirillum magneticum strain AMB1.28 Magnetosome formation involves three steps: invagination of cytoplasmic membrane to
form magnetosomes, assembly into a chain templated by proteins Mamk and MamJ, and
transport of iron into vesicles and synthesis of magnetite crystals with definite shape and size,
which is initiated by Mms6.25, 28

9

1.5.3 Bacterial Biomineralization Protein-Mms6
There are some proteins that are specific to the membrane and are responsible for magnetite
crystal growth. One such protein Mms6 was first reported by Arakaki et al who characterized a
number of proteins in Magnetospirillum magneticum strain AMB-1. Mms5, Mms7, Mms13 were
few other proteins that were isolated and characterized.5 All these proteins have a hydrophobic
N-terminal region and a hydrophilic C-terminal region. The most interesting conclusion from
this report is that magnetite nanoparticles with similar morphology to bacterial magnetite
particles can be synthesized in vitro in the presence of purified recombinant Mms6 expressed in
E.coli. Figure 3 shows the electron micrographs of magnetic particles synthesized in presence
and absence of Mms6.5

Figure 35

: A) iron crystals in presence of Mms6 B) iron crystals in absence of Mms6

Iron produced in the presence of Mms6 showed cuboidal morphology, with size ranging from 20
to 30 nm (Figure 3A), whereas the magnetic particles produced in absence of Mms6 were nonhomogeneous in size (1-100nm) (Figure 3B). In 2007, Prozorov et al. reported magnetization
measurements and structural characterization of magnetite nanoparticles synthesized in presence
of recombinant Mms6.37 BSA, ferritin and Lcn2 were used as controls to compare magnetite
particles synthesized in presence of proteins with different iron binding properties. These reports
showed that magnetite particles with uniform morphology can only be synthesized in presence of
recombinant Mms6.37
Prozorov et al. reported the synthesis of cobalt ferrite nanocrystals in the presence of HistidineMms6 (His-Mms6) and its C-terminus.38 They covalently attached His-Mms6 to self-assembling
10

polymers to act as a template for synthesizing cobalt ferrite nanocrystals. Alternatively cobalt
ferrite nanocrystals were synthesized by attaching C-terminus of Mms6 to self-assembling
polymers. Complex magnetic crystalline nanomaterials of particle size 40-100nm were produced
, and these sizes with high degree of crystanility are difficult to produce using conventional
techniques. The hydrophilic C-terminal region of Mms6 contains amino acid residues with either
hydroxyl or carboxyl groups. The Figure 4 shows amino acid sequence of Mms6.
AKTGVATAVAAPAAPANVAAAQGAGTKVALGA
GKAAAGAKVVGGTIWTGKGLGLGLGLGLGAWG
PIILGVVGAGAVYAYMKSRDIESAQSDEEVELRDALA
Figure 4: Amino acid sequence of Mms6 deduced from the DNA sequence.

Arakaki et al. proposed that Mms6 may act as a template for magnetic nanoparticles synthesis
and control the morphology of magnetite particles formed.5 The exact role of Mms6 in magnetite
crystal formation remains still unclear.

1.6 Applications of Magnetic Nanoparticles
No matter the method of synthesis, the magnetic nanoparticle has a number of potential
applications. Magnetic nanoparticles are widely being used for cell separation,39 automated DNA
extraction,40 drug delivery and targeting41 and magnetic resonance imaging.8 Nontoxicity,
biocompatibility and injectability are the important properties of magnetic particles which make
them potential candidates for application in medicine. Magnetic cell separation has been carried
out using antibodies that bind to proteins. DNA extraction is an important technique for DNA
sequencing, and an automated DNA extraction process is useful in clinical fields. DNA can be
separated from cell contaminants and debris by using magnetic particles. Use of magnetic
particles over conventional separation methods reduces use of chemicals and increases the ease
of separation of DNA.40
Chemotherapeutic drugs are non-specific and this nature makes them disadvantageous for
various tumor treatments. Instead of attacking the tumor cells they also attack normal, healthy
11

cells. Use of magnetic nanoparticles as carriers for cytotoxic drugs increases the uptake of drug
at the target site. Therapeutic compounds are attached to biocompatible magnetic nanoparticles
and high magnetic fields are used to guide the drug to tumor locations.41 Magnetic particles are
attracted to higher magnetic flux density and this feature is used in drug targeting. Currently,
magnetic nanoparticles are being used as contrast agents for magnetic resonance imaging. Figure
5 is a schematic illustration of the therapeutic strategy using magnetic nanoparticles. Magnetic
particles can be used for diagnosis as well as cancer therapy simultaneously. Use of magnetic
nanoparticles is slowly increasing in many fields.

Tumor

Magnetic
Nanoparticle
s

Hyperthermia

MI sensor
DDS
MR
I

Therapy

Diagnosis
Figure 541: Functionalized magnetic nanoparticles accumulate in the tumor tissues via the drug delivery
system (DDS). Magnetic nanoparticles can be used as a tool for cancer diagnosis by magnetic resonance
imaging (MRI). Hyperthermia can be induced using alternating magnetic fields.

With these applications, synthesizing particles of specific size and shape by methods conducive
for subsequent biomedical use is of great importance.
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1.7 Purpose of Study
It is clear that protein mediated synthesis of magnetic nanocrystals is a potential route for
synthesis of well defined nanoparticles. Nanoparticles can be produced extracellularly, by
making use of bacterial mineralization proteins against conventional chemical routes which often
involve high temperatures and pressures. One such protein, Mms 6, isolated from the strain
Magnetospirillum magneticum strain AMB-1 showed the ability to bind iron to produce
homogeneous magnetic nanoparticles. Binding of iron was attributed to the presence of hydroxyl
and carboxyl groups present in the C-terminal hydrophilic region. The amino acid residues that
possibly bind iron in Mms 6 sequence are bolded.
Mms 6

GAVYAYGKSRDIESAQSDEEVELRD

Serine(S), aspartic acid (D), glutamic acid (E) and tyrosine (Y) are the amino acid groups with
functional groups hydroxyl and carboxyl, their structures are given in Table 2.
Table 2: Amino acids and their Structure

Amino Acid

Structure

Serine (C3H7NO3)
Aspartic

Acid

(C4H7NO4)
Glutamic

Acid

(C5H9NO4)
Tyrosine (C9H11NO3)

The following sets of sequences were designed as variations in amino acids in Mms 6. VA1 has
only hydroxyl groups(S, Y), VA2 has only carboxyl groups (D, E), and VA3 has combination of
both hydroxyl and carboxyl.
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The above sequences are designed in order to compare with the sequence that is available from
literature. Table 3 shows the newly designed peptides.
Table 3: Designed Peptides
VA1

GAVYAYGKSRSIYSAQSYSSVSLRY

VA2

GAVDADGKERDIDEAQEDEEVDLRD

VA3

GSEDAYGSYDESYDEQSEDYESYYS

The project addressed in this proposal involves inspecting the relative ability of functional
peptides to bind iron by changing the amino acid sequence and most importantly to see whether
there is a change in the shape of crystals formed with different peptide functionality.39 The three
sequences were designed to test to what extent carboxyl and hydroxyl functional groups play a
role in binding iron.
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Chapter 2
Materials and Methods
Production of protein polymers via biologically directed methods helps to create molecules with
well defined sequences and functionality. These properties cannot be controlled in chemically
synthesized molecules. A cloning strategy (Figure 6) for production of protein polymers is
employed. Figure 6 shows how an insert is cloned and expressed in DNA plasmids to produce
amino acid polymers.

Figure 6 : Cloning strategy used for synthesis of amino acid

2.1 Materials
E.coli plasmids pUC19, pET19b and pET24a were purchased from Invitrogen (Carlsbad, CA).
Restriction endonucleases were obtained from MBI Fermentas (Hanover, MD), and New
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England Biolabs (Beverly, MA). Oligonucleotide and plasmid purification kits and nickelcheleated sepharose resin were obtained from Qiagen (Valencia, CA). General reagents for
protein expression and purification were purchased from Sigma (St. Louis, MO) and Fisher
Scientific (Fairlawn, NJ). All inserts in initial phase of research were obtained from Invitrogen,
while altered pJ414express, pJ201, and pJ241 were obtained from DNA 2.0 (Menlo Park, CA).

2.2 Design of New Plasmids and Ongoing Research Work
The oligonucleotide sequence of Mms612 described by Atsushi Arakaki et al. was modified as
VAMms6. Other sequences were designed by replacing amino acids in Mms6 with hydroxyl and
carboxyl amino acids to test how functionality differences affect binding of iron and nucleation
of magnetic nanoparticles. These three sequences, VA1, VA2, and VA3 were designed for
comparison with the control VAMms6. Figure 7 shows the sequences. Change in the sequences
may alter the binding of iron to the peptides formed. VA1 contains functionality of hydroxyl
groups from the side chains of serine (S) and tyrosine(Y). VA2 contains only carboxyl functional
groups i.e. aspartic acid (D) and glutamic acid (E). VA3 contains both hydroxyl and carboxyl
functional groups. These designed sequences were ordered in the cloning plasmids pJ201 or
pJ241 from DNA 2.0. The inserts were designed with BamH1 and HindIII ends to ensure a
proper ligation of the inserts into the expression plasmid pET24a. The DNA was received as 2µg
of dry DNA and a stab culture in NEB-10 Beta cells. Cell stocks were made from the stab culture
by streaking on plates with solid media containing kanamycin, matching the antibiotic resistance
of pJ201 and pJ241.
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Figure 7: DNA sequence of new designed inserts with BamH1 and HindIII ends (* denotes stop codon)

2.3 New Expression Construction
The cloning plasmids were digested with enzymes BamH1 and HindIII for 30 min at 37°C in an
incubator. The inserts were purified via 1% agarose gel electrophoresis. The expression vector
pET24a was also digested with enzymes BamH1 and HindIII for 30 min at 37°C in an incubator.
pET24a was dephosphorylated via treatment with CIP and purified using nucleotide removal kit.
The inserts VAMms6, VA1, VA2 and VA3 were then ligated into pET24a. The ligated mixture
was then transformed into chemically competent BL21 cells and 50µl of culture was spread on
plates with solid media containing ampicillin and chloramphenicol antibiotics. These plates were
incubated overnight at 37°C in an incubator.
The peptide sequences of VAMms6, VA1 and VA2 were ordered in expression vector pJ414.
These sequences were ordered to eliminate the steps of ligation of insert into the expression
plasmid. DNA was received as 2µg of dry DNA and a stab culture in NEB-10 Beta cells. Cell
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stocks of VAMms6, VA1, and VA2 were made from the stab culture by streaking on plates with
solid media containing ampicillin. Dry DNA was suspended in 20µl of sterile water. DNA was
transformed into chemically competent BL21 cells. The cells were spread onto petri dishes with
solid media containing ampicillin and chloramphenicol antibiotics. These plates were incubated
overnight at 37°C in an incubator. Single colonies were obtained from the petri dishes and put
into 5ml cultures of liquid media. Culture tubes were shaken and placed in an incubator
overnight at 37°C. Cell stocks of VAMms6, VA1, and VA2 in BL21 cells were made for future
use in peptide expression. 50 mg of peptide VA3 was ordered from (Genscript, NJ). VA3 was
ordered to carry out co-precipitation reaction with iron solution and analyze the particles formed
under a Transmission electron microscopy (TEM).

2.4 Protein Expression
Cells from the cell stock of VAMms6, VA1 and VA2 in BL21 cells were used to inoculate a 50
ml starter culture in 2xTY media containing ampicillin (200µg/ml) and chloramphenicol
(35µg/ml). Starter culture was shaken in an incubator overnight at 37°C. 500ml of 2xTY media
was inoculated with 10 ml of the starter culture and 500 µl of each antibiotic ampicillin and
chloramphenicol. This culture was shaken in an incubator at 37°C until the optical density
measured at 600nm (OD600) reached a value of to 0.8±0.1. At that point, protein expression was
induced by the addition of 500 µl (0.41M) of isopropyl-β-D-thiogalactopyranoside (IPTG) and
the cultures were grown for 4 more hours. After addition of IPTG, OD of samples was taken
every one hour. At the end of 4 hours, cells were harvested by centrifugation (7000rpm, 15min),
the supernatant was discarded, and the cell pellets were resuspended in 8M Urea Buffer at pH 8
(1g cell/5 ml of buffer) and stored in -20°C freezer. The samples that were collected during
protein expression were also centrifuged and the cell pellets were resuspended in TE Buffer.

2.5 Protein Purification
The suspended cell pellets in 8M urea buffer were thawed before sonication. Sonication was
performed for 50 seconds with 2 seconds pulse on and 10 seconds pulse off. The cells were then
centrifuged at 10000 × g for 30 min to remove the cell debris. At the end of the centrifugation,
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the supernatant was saved and the cell debris that precipitated at the bottom was discarded. The
reserved supernatant was then incubated with Nickel-NTA resin for an hour at room temperature,
shaking the beads continuously. The unbound proteins were separated from the nickel resin using
a gravity-flow column. The flow-through of unbound molecules was saved for SDS-PAGE
analysis. The nickel resin was washed with different pH buffers of 8M urea. First, a urea buffer
of pH 6.3 was used to wash the column. Then, the target proteins were eluted with urea buffers
of pH 5.9 and pH 4.5. Optical density measurements were taken at 280 nm wavelength. All the
flows through fractions from the wash steps were saved for future analysis by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE).

2.6 SDS-PAGE
Induction profiles were observed for all the peptides by running SDS-PAGE of samples that
were collected during protein expression, before and after induction. Similarly protein
purification profiles were also obtained via SDS-PAGE. The separating gels were made at 15%
polyacrylamide concentration while the stacking gels were made at 6% polyacrylamide
concentration. All the wash fractions from protein purification were loaded and the gel was run
at 100V for 90 min. The gels were visualized using Coomassie blue stain. The gels were stained
for 30 min and then destained overnight at room temperature.

2.7 Amino Acid Analysis
After purification of the peptides, the peptides were dialyzed and stored at -80°C. They were
freeze dried, and the lyophilized material was sent out for amino acid analysis to confirm the
presence of the desired peptides. All peptide samples were sent to the UC Davis Proteomics
Core Facility for analysis.
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2.8 Western Blots
Western Blots were used to confirm the presence of the desired peptide with a His-tag.
SDS-PAGE was run to separate the proteins by the length of the polypeptides. The proteins were
transferred onto a PVDF membrane by electrophoresis for 1h 15min at 45v. The membrane was
washed in Tris-buffered saline (TBS) for 5 minutes and blocked using a blocking buffer
purchased from Qiagen. The membrane was washed three times with TBS with Tween-20 (TBST) for 5 minutes a wash. The membrane was incubated with anti-His antibody at a dilution of
1:2000 in blocking buffer overnight. The membrane was washed three times with TBS-T. The
first wash was for 5 minutes, the second and third was for 10 minutes and 15 minutes
respectively.

A

chemiluminescent

technique

was

used

to

detect

the

florescence.

Chemiluminescent is a technique that involves incubation of the western blot with a substrate
and in the process light is emitted due to a chemical reaction. The membrane was developed in
1ml of lumiglo for one minute. The florescence of the antibodies was detected by placing the
membrane on a plastic film and exposing the film for two minutes.

2.9 Synthesis of Magnetite nanoparticles using recombinant proteins
Magnetite nanoparticles were synthesized via co-precipitation of FeCl2 and FeCl3 aqueous
solutions in the presence of one of the recombinant proteins, VA-Mms6, VA1, VA2, or VA3.
The following stoichiometric reaction is a balanced equation of magnetite formation.
Equation 1: Stoichiometric equation of magnetite formation
FeCl 2  2FeCl 3  8NaOH  Fe3 O 4  8NaCl  4H 2 O

4Fe3 O 4  O 2  6Fe 2 O 3 ................. Undesired Reaction
The undesired reaction takes place if the reactants are exposed to atmosphere. The synthesis of
magnetite nanoparticles was carried out in a glove box in order to provide the reaction media an
inert nitrogen atmosphere. 100µl of 0.6M FeCl3 and O.3M FeCl2 were added to 10µl of peptide
solution (5mg/ml) in a 10ml round bottomed flask. All the solutions were degassed with argon
for 3 minutes prior to their use. The reaction mixture was titrated slowly with 0.1N NaOH
solution under constant nitrogen flow. As the titration progressed, the initial pale yellow solution
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slowly changed to brownish-yellow and finally to black. The formed iron particles were left to
grow in sealed flasks for 7 days. At the end of 7 days, particles settled to the bottom of the flask
and were further concentrated at the bottom using boron-neodymium magnet. The precipitate
was then washed with degassed water and vacuum dried overnight at room temperature.
Synthesis of magnetite was also carried out using polyethylene glycol (PEG) attached to the
peptides VA2 and VA3. PEG was dissolved in 1ml of DMSO. To this VA2 or VA3 (1mg/ml),
HBTU solution (a peptide coupling reagent) and N, N-Diisopropylethylamine (DIEA) were
added. Definite volumes of HBTU and DIEA were added every 3 hours and the whole reaction
mixture was stirred at room temperature overnight. The reaction mixture was dialyzed and stored
in -80 °C freezer. The coupled peptides (PEG-VA2 or PEG-VA3) were used to synthesize iron
particles similar to the methods used with VAMms6, VA2 and VA3 to synthesize iron particles.

2.10 Characterization of Magnetite Nanoparticles
2.10.1 Scanning Electron Microscopy
Energy dispersive X-ray spectroscopy (EDS or EDX) is an analytical technique used for the
elemental analysis or chemical characterization of a sample. The samples were imaged by
scanning electron microscope and analyzed by EDS. The precipitate was dried on a copper tape
stuck to an aluminum stub. The copper tape was used to increase conductivity and smoothness of
surface. EDS was performed by Adrienne MacLeod McGraw. (WVU)
2.10.2 Transmission Electron Microscopy (TEM)
For TEM specimen preparation, the sample was first diluted with ethanol. After the solution was
sonicated for about 10 minutes, a drop of the solution was transferred to a 200 mesh copper grid
with carbon support and was then left to dry in ambient condition. TEM characterization was
performed using a JEM-2000FX operating at 200kV. Selected area electron diffraction (SAED)
was also performed on the samples. TEM was done by Dr. Chaoying Ni (University of
Delaware).
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2.10.3 X-ray Photoelectron Spectroscopy (XPS)
XPS is a quantitative technique used to measure elemental composition, chemical state and
electronic state that exists in a material. The XPS system used in these studies was a Physical
Electronics 5700 ESCA system, equipped with both a standard Al/Mg x-ray source (energies of
1456/1253 eV respectively) and a monochromatic Al source. The system was calibrated to the
Au 4f7/2 peak to ensure linearity in the (binding) energy scale. The dried precipitate was placed
on a silicon wafer and XPS was performed by Srikanth Raghavan. (WVU)
2.10.4 Dynamic Light Scattering
The size of particles synthesized were determined by dynamic light scattering (DLS; DLS-7000,
Otsuka Electronics) for a sample dispersed in aqueous suspension after vortexing. The median
diameter (number basis) was determined from the obtained size distribution. Dynamic light
scattering was done with the help of Aaron Kessman.
2.10.5 Atomic Force Microscopy (AFM)
All atomic force microscopes have the same basic components: laser, cantilever, photodiode,
controller, scanner, and computer. In AFM, the force transducer is a deflecting cantilever on
which a sharp tip is mounted. The cantilever and tip assembly is scanned with respect to the
surface to get the morphology of the surface. Using the laser light reflected from the cantilever
back, a photodiode collects data on the deflection of the cantilever.
The system used for our measurements was calibrated using standards produced by Mikro-Mash.
The standards used for this step were 20 nm ±1 in height. The AFM was mounted on a Minus K
vibration isolation table inside of a Herzan acoustic isolation hood. The precipitate was vacuum
dried on silicon carbide wafers and AFM was performed. AFM was performed with the aid of
Srikanth Raghavan (WVU).
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2.10.6 Magnetic Force Microscopy (MFM)
Magnetic force microscopy was performed on the samples. For the MFM, the tips have to be
magnetic in nature. Magnetic nature enables the tip to detect any magnetic force from the sample
onto the tip. All tips vibrate at a natural frequency called the resonance frequency. The thickness,
length and width were typically 3μm, 225 μm and 28 μm respectively. The natural frequency or
the resonance frequency of the tips was around 75 kHz. MFM instrument which was used for the
purpose of this research is (manufactured by Agilent Technologies formerly Molecular Imaging,
product name: 5500 SPM).
The height at which the tip is placed is called the “Interleave Height” or simply “Lift Height”.
Net magnetic force depends heavily on the tip-sample separation or the „interleave height‟. The
interleave height used for this research was 100 nm. It is important that the interleave height be
greater than the highest features of the surface topography, if not the probe could actually crash
into the sample surface. In order to maintain a constant interleave height throughout the
experiment, the tip is usually pulled away from the sample by a value well above the interleave
height and then brought back to the level of interleave. This particular value of pulling away
from the sample is called as “Pullaway Height”. The pullaway value used for this research was
300nm. MFM was performed with the help of Srikanth Raghavan. (WVU)

23

Chapter 3
Results and Discussions
VAMms6 was ordered in expression vector pJexpress414, whereas VA1, VA2 and VA3 were
ordered in cloning vector pJ201. The oligonucleotides VA1, VA2, and VA3 which are 170bp
long, were digested from cloning vector pJ201 using the enzymes BamH1 and HindIII. Figure 8
shows the agarose electrophoresis gel of digested inserts.

pJ201
1500bp

200bp
100bp

Inserts VA1, VA2, VA3
VA4
1

2

3

4

Figure 8: Lane 1) 100bp Ladder, Lane 2) VA1, Lane 3) VA2, Lane 4) VA3, 1.5% gel, 40 min @ 100V, stained
with SYBR gold

Two bands were observed in each lane numbered from 2 to 4 in Figure 8. One band was seen
above 1500 base pair and other band was seen approximately at 200 base pairs as seen in
comparison to the molecular weight ladder in lane 1. These bands are at the expected molecular
weight of the insert (170bp) and the remainder of the plasmid after digestion. The observed
bands of inserts were cut from the agarose gel and purified using a Qiagen purification kit. In
order to transfer inserts VA1, VA2 and VA3 into expression plasmid, pET24a was digested with
BamH1 and HindIII, later purified using nucleotide removal kit.
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An agarose gel was run to determine the concentration of the insert and vector for subsequent
calculations of ligating the inserts into the expression plasmid pET24a. Figures 9(a) and 9(b) are
the images of concentration gel.

1

2

3 4

5

6

pET24a

5kb

200bp
100bp
(a)

Inserts VA1, VA2, VA3

(b)

Figure 9 (a): Lane 1) 1 kb ladder, Lane 2) digested pET24a, (b) Lane 3) 100bp ladder, Lane 4) VA1,
Lane 6) VA2, Lane 7) VA3, 1.5% gel, 35 min @ 100V, and stained with SYBR gold

In comparison to the molecular weight ladders, a band was observed at about 5000bp as seen in
Figure 9(a) and bands were observed at around 200 base pairs as seen in Figure 9(b). These
bands were at the expected molecular weight of the digested pET24a (5140 bp) and the inserts
(170 bp). The concentrations of the DNA segments were determined by comparing the
fluorescence intensity of the sample DNA with that of the band of comparable size in the 100bp
DNA ladder, which contains a known concentration of DNA. Similarly, concentration of
digested expression plasmid pET24a was determined by comparing the fluorescence intensity of
digested pET24a with the fluorescence intensity of the closest corresponding band in the 1kb
DNA ladder. The relative intensity of the inserts was taken to be half of the intensity of 200 bp
marker, indicating a concentration of approximately 12ng/µl. The expression plasmid had the
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same intensity as that of 5kb marker and therefore is at a concentration of approximately
42ng/µl. The volume of both insert and vector needed for a ligation was calculated using
equation (2).42

Vv 

T
 Vc  I l  I r

 I c  Vl


  1


;

I v  T  Vv

(2)

where, T is the volume of total ligating solution, Vl is the vector length, Vc is the vector
concentration, Vv is the vector volume, Il is the insert length, Ic is the insert concentration, Iv is
the insert volume and Ir is the required insert-to-vector ratio for ligation.
Ratios of 300:1 and 600:1 (insert:vector) were used for ligation of inserts into vector pET24a.
The ligated DNA was transformed into BL21 cells but the ligations were unsuccessful as there
were no colonies on petri dishes. The ligations proved futile and hence to eliminate the ligation
steps, VA1 and VA2 were ordered in expression plasmids pJexpress 414.

3.1 Protein Expression
Cells from the cell stock of VAMms6, VA1 or VA2 in BL21 were used to inoculate a 50ml
starter culture in 2xTY media containing ampicillin (200µg/ml) and chloramphenicol (35µg/ml).
A starter culture was shaken in an incubator overnight at 37°C. Culturing media (500ml) was
inoculated with 10ml of the starter culture and 500µl of each antibiotic ampicillin and
chloramphenicol. Table 4 gives the optical density values measured at different times during
expression.
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Table 4: Optical density values of pJexpress414-VAMms6, pJexpress414-VA1, and pJexpress414-VA2
expressed in BL21 strain
pJexpress414 –
VAMms6 (Time
in hours)

Optical density
at 600nm (BL 21
cells)

pJexpress414
–VA1 (Time in
hours)

Optical density
at 600 nm (BL
21 cells)

pJexpress414 –
VA2
(Time
in hours)

Optical density
at 600nm (BL 21
cells)

2.5
0.791
2.5
0.769
2.5
0.773
3.5
1.19
3.5
1.52
3.5
1.55
4.5
1.30
4.5
1.95
4.5
1.90
5.5
1.73
5.5
2.05
5.5
2.10
6.5
1.80
6.5
2.54
6.5
2.25
*time points after 2.5, samples were diluted to determine the OD value. Values reported are corrected with the
dilution factor 1/10

The cells that were harvested after expression were purified under denaturing conditions.
Purification under denaturing conditions involves a series of washes with 8M urea buffer at
different pH values of 6.3, 5.9 and 4.5. The purified fractions were collected and analyzed on a
SDS-PAGE gel. The gel was visualized using Coomassie blue staining. Figure 10 shows the
elution samples of VAMms6, VA1 and VA2 respectively, after purification.
1

2

3

4

37 kD

Protein

Mol.wt.

25 kD
20 kD

VA-Mms6

8.7 kD

VA1

7.8 kD

VA2

7.9 kD

15 kD
10 kD

VA-Mms6
VA1

VA2

Figure 10: Protein purification profile of VA-Mms6, VA1 and VA2, 12.5 % separating gel, ran @100V,
Lane1) Protein ladder, Lane 2) VA-Mms6 Lane 3) VA1 and Lane 4) VA2

Two bands were observed in lane 2, one between 10 kD-15 kD and the other between 20 kD-25
kD as compared to the molecular weight ladder in lane 1. VA-Mms6 (8.7 kD) is expected to run
higher due to the presence of highly charged functional groups. A second band seen at around
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20kD reveals the folding of peptide VA-Mms6. In lane 3 there were no bands. Repeated number
of purifications did not yield VA1; reason being VA1 was not properly expressed. In case of
VA2, as seen in lane 4, there was a single band seen at roughly 10 kD. This band is slightly
higher than expected, owing to the presence of negatively charged carboxyl functional groups in
VA2. This purification profile showed that VA-Mms6 and VA2 were reproducible whereas,
VA1 cannot be expressed and hence is not used in further study.

3.2 Amino Acid Analysis
The results from amino acid analysis are shown in Appendix A. After purification and
lyophilization, samples were sent out for amino acid analysis. The amino acid analysis was
performed by digesting the peptide with HCl and reducing the peptides to their amino acid
components. The digested material was analyzed using chromatography. The result was reported
in nmol/injection of each amino acid. Based on the amino acids present in the peptides, the
percent content of each amino acid was compared to the expected percent. It is seen that the
deviation of the observed results were less than ±2% of the expected value. The observed and
expected mole percentage of amino acids was in good agreement with the amino acid analysis of
the peptides VA-Mms6 and VA2, indicating that proteins of interest had been produced. Amino
acid analysis was done at UC, Davis CA in Proteomics Core Facility.

3.3 Western Blot
A western blot was run to detect proteins with His-tag. Western blot is an electrophoretic
technique where the proteins are separated based on their charge and mass. Specific antibodies
are used to detect the presence of specific proteins. A chemiluminescent detection method was
carried out to visualize the proteins. Figure 11 shows the western blot image of VA-Mms6, VA1
and VA2.
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Figure 11: Western Blot Stained with anti-His antibody, Lane1) purified His-tagged VA-Mms6; Lane 2)
purified His-tagged VA1; Lane 3) purified His-tagged VA2

The protein bands that were visible on the SDS-PAGE were also observed on the PVDF
membrane at the same molecular weight, confirming the presence of proteins. For VA-Mms6 in
lane 1, we observed a band at a higher molecular weight, which might be due to protein folding
present in the VA-Mms6 peptide. As seen in lane 2, VA1 was not observed which is in
consistent with the PAGE gel. A band was seen in lane 3 for VA2, confirming that the desired
peptide was correctly expressed and purified. The His-ladder did not get resolved properly,
because the ladder was not heated before loading into the wells. Changing the volume of ladder
to be loaded and heating prior to loading might help in better resolution. Western Blot was done
at Health Science Centre, WVU Morgantown WV with the help of Dr. Yogesh Kulkarni.

3.4 Synthesis of Magnetite Nanoparticles
To confirm that VA-Mms6, VA2 and VA3 can stimulate the formation of magnetite particles
with defined structures, we have synthesized magnetite particles in the presence of VA-Mms6,
VA2 and VA3. Figure 12(a) shows the SEM image and Figure 12(b) shows the EnergyDispersive Spectrum (EDS) of particles synthesized in the presence of VA-Mms6.
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Figure 12: (a) SEM image of iron particles synthesized in the presence of VA-Mms6 (b) EDS of iron particles
synthesized in the presence of VA-Mms6

The particles synthesized in the presence of VA-Mms6 were confirmed to be iron particles by
performing EDS. The iron and oxygen peak seen in the Figure 12(b) can be related to the
presence of iron oxide particles. A large peak of copper is seen as it was used as a surface to dry
the particles and hence it is the background. Carbon peak in the spectrum comes from the
backbone of the peptide. However, the particles were heavily aggregated as seen in the SEM
image. The reason for the aggregation is due to the presence of high charge surface on the
peptide that nucleates the formation of iron particles.
Figure 13(a) and Figure 13(b) show the SEM and EDS of particles synthesized in the presence of
VA2. EDS analysis reveals the presence of iron particles. The peaks seen in Figure 13(b) can be
attributed with the same reasoning as given for peaks in EDS in Figure 12(b) (above).
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Figure 13: (a) SEM image of iron particles synthesized in the presence of VA2 (b) EDS of iron particles
synthesized in the presence of VA3

Similarly, SEM and EDS of synthesized particles in presence of VA3 is shown in Figures 14(a)
and 14(b), respectively.

VA3 8/18/10 pic 01 spec
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Figure 14: (a) SEM image of iron particles synthesized in the presence of VA3 (b) EDS of iron particles
synthesized in the presence of VA3

Due to the presence of high-charge density on VA3 the synthesized particles were aggregating to
a greater extent. EDS of the particles reveals that the synthesized particles in the presence of
VA3 are iron particles. The same trend of iron, oxygen and copper peak was seen in Figure 14(b)
as in Figure 12(b) and Figure 13(b). All the SEM measurements were performed by Adrienne
McGraw (WVU).
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Magnetite particles were also synthesized using polyethylene glycol (PEG). Figure 15 shows the
SEM image of magnetite particles formed in the presence of PEG-VA2 and PEG-VA3.

(a)

(b)

Figure 15: SEM Image of magnetite particles synthesized in presence of (a) PEG-VA2 (b) PEG-VA3

There was greater tendency in the aggregation of particles when biocompatible polymer like
PEG was attached to the peptides VA2 or VA3 to synthesize iron particle, Figure 15 depicts the
same tendency. Characterization of iron particles synthesized with PEG-VA2 or PEG-VA3 can
be carried out as future work for further qualitative and quantitative details of iron particles.

3.5 Transmission Electron Microscopy (TEM)
There was a huge difficulty in looking at the particles through SEM for particle size ranging
from 50 to 100 nm, due to aggregation of particles. Due to the inherent limitation of SEM to
provide only surface analysis, TEM was used to provide detailed sectional analysis in nanoscale, which can be used to study synthesized iron particles for present work.
Figure 16 shows the TEM images of iron particles synthesized by co-precipitation of FeCl2 and
FeCl3.
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(a)

(b)

(c)
Figure 16: TEM Images of magnetite particles synthesized in presence of (a) VA2 (b) VAMms6 (c) VA3

The iron particles synthesized in the presence of VA2 (Figure 16a) were discrete, exhibiting a
size range of 50 nm forming stable single magnetic domains. The iron particles exhibited a
definite morphology. The iron particles synthesized in the presence of VA-Mms6 (Figure 16b)
and VA3 (Figure 16c) were highly aggregated making it difficult to locate individual particles,
due to this reason images of iron particles did not show a defined morphology in either of the
case. VA2 has more number of carboxyl groups than VA-Mms6 and VA3. Discrete particles
were seen when VA2 was used showing that the high charge of carboxyl groups was responsible
in nucleating iron particles in size range of 50 nm. Particles synthesized with the aid of VA2
were found to be similar in size and morphology with those produced by Arakaki et al.
Visualization of particles synthesized with the aid of VA-Mms6 and VA3 was difficult. The
sample preparation for TEM was done by Dr.Chaoying Ni. All the TEM measurements were
performed by Dr. Chaoying Ni (University of Delaware).
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3.6 X-Ray Photoelectron Spectroscopy
XPS was run to determine the elemental composition and chemical state of the elements present
in the sample. Figure 17 shows the XPS spectra of the synthesized iron particles in presence of
VA-Mms6, VA2, VA3 and standard Fe3O4 respectively.
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Figure 17: XPS spectra of magnetite particles synthesized in the presence of VA-Mms6, VA2, VA3 and XPS
spectra of standard magnetite particles

XPS spectrum of individual samples is shown in Appendix B. A detail of the iron peaks (Fe
2p1/2 and Fe 2p3/2) can be seen in Figure 17. The 2p3/2 peak shows a binding energy with a FeII
component. In addition; in this case, the XPS analysis was very important in verifying the
oxidation state of iron. The FeII/FeIII ratio, experimentally measured in different magnetite
samples, ranged from 0.33 to 0.67. In the XPS spectrum, the binding energy signals appears at
724.4 eV and 711.0 eV, which are the 2p electron orbit of iron atom in Fe3O4.43 In Figure 17
XPS spectra of magnetite particles synthesized in presence of VA-Mms6 closely matches to the
standard magnetite particle spectra. The XPS spectra of particles synthesized in the presence of
VA2 and VA3 have a slight shift in the binding energy signals when seen in comparison to the
standard. The shift in the peaks is due to the presence of Fe+2 and Fe+3 in non-stoichiometric
ratios. A satellite is seen in all the spectra most likely because of electron transfer from a ligand
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(oxygen) to a normally empty valence level in Iron. The XPS analysis confirmed that the
synthesized oxide was magnetite and was successfully synthesized in the presence of peptides
VA-Mms6, VA2 and VA3. However particles synthesized in presence of VA2 and VA3 showed
non-stoichiometric ratios of iron in magnetite. XPS was done by Srikanth Raghavan (WVU).

3.7 Dynamic Light Scattering (DLS)
In order to determine the size of synthesized magnetite particles in the presence of peptides,
dynamic light scattering was performed. Figure 18 shows the size distribution of synthesized
magnetite particles.

(a)

(b)

Peak Diameter
VAMms6

88 nm

VA2

62 nm

VA3

41 nm

(c)
Figure 18: Size distribution of particles synthesized in the presence of (a) VA-Mms6 (b) VA2 and (c) VA3

Particles synthesized in the presence of VA-Mms6 had a maximum distribution at a peak
diameter of 88nm. Particles synthesized in the presence of VA2 and VA3 showed maximum size
distribution of particles at a peak diameter of 62nm and 41nm respectively. Particles of size
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range 35-120nm form stable single magnetic domains and the magnetite particles synthesized in
the presence of all the peptides fall in this size range. Particles synthesized using Mms6 by
Arakaki and et al. was of size range 30 to 40nm. Magnetite particles synthesized in the presence
of VA2 and VA3 closely matches with those produced by Mms6. The size range of VA2 was
around 40nm when observed using a magnetic force microscopy against 60nm seen using
dynamic light scattering. A possible reason is that the individual particles located in the scan
region of magnetic force microscopy were of order 40nm. Dynamic light scattering was done
with the help of Aaron Kessman. (WVU)

3.8 Atomic Force Microscopy (AFM)
Fe3O4 particles were dried on a silicon carbide wafer; this wafer was analyzed using AFM to
observe the surface for magnetite particles. Particles were scanned in an area of 5µm×5µm.
Figures 19(a), 19(b) and 19(c) show the AFM images of magnetite particles synthesized in
presence of VA-Mms6, VA2 and VA3 respectively.

(a)
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(b)

(c)
Figure 19: AFM image of magnetite particles synthesized in the presence of (a) VA-Mms6 (b) VA2 (c) VA3

The left half of each AFM image is the topography and the right half is the phase. The
agglomeration of particles is seen in all the topography images. In case of magnetite particles
synthesized in presence of VA-Mms6 they appeared more like a cloud whereas in presence of
VA2 uniform size of particles is seen with defined morphology. In presence of VA3 magnetite
particles are very difficult to locate individually. There was a difficulty in sample preparation as
the particles agglomerated during drying. AFM was performed with the help of Srikanth
Raghavan (WVU).
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3.9 Magnetic Force Microscopy (MFM)
Magnetic force microscopy was done on particles synthesized in presence of VAMms6, VA2
and VA3 in order to find magnetic domains. Figure 20 shows the MFM image of magnetite
particles synthesized in the presence of VA2.
Individual particle of size range 40nm

Figure 20: MFM image of magnetite particles synthesized in presence of VA2

The first part of the MFM analysis consisted in locating a region where individual particles can
be seen in domains. In this region, lift mode MFM revealed that all the domains stay in different
directions with defined parallel strips due to the anisotropy. Well-defined walls and domains
shifts were interpreted as negative (repulsion) in bright regions, while positive (attraction) in
dark regions. Domains formed in the magnetic field were measured in a range of 30–40nm by
the profile following transversal direction across the domains.
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Magnetic domains were seen only in the case of particles synthesized in presence of VA2
(Figure 20). This confirmed the magnetic nature of particles formed. The size range of particles
(40nm) observed falls in the region of particles with single magnetic domains. This is a slight
decrease in the size of particles when seen against dynamic light scattering results for particles
synthesized using VA2. In case of particles synthesized with the aid of VAMms6 and VA3,
individual particles could not be located because of aggregation. Another possibility is that the
polymer is covering the particles making it even more difficult for the magnetic interactions to
be seen as an image. Care should be taken that the interleave height is small enough for the
magnetic interactions between the tip and surface to be seen. Very small heights might crash the
tip. So, an optimum interleave height of 100nm should be maintained. MFM image of VA2
confirms the presence of magnetite nanoparticles with single magnetic domains of the size 40nm.
MFM was carried out with the help of Srikanth Raghavan (WVU).
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Chapter4

Conclusions and Future Directions
The proposed mechanism in this study states that the Mms6 is a magnetosome membraneassociated protein and the hydrophilic C-terminal domain, which contains acidic acids, forms a
negatively charged surface. The carboxyl groups together with hydroxyl groups may serve as the
template for iron binding and the formation of magnetite particles with defined size and
morphology.
The investigation of sizes and morphologies of magnetite nanoparticles synthesized in the
presence of VAMms6, VA2 and VA3 suggested that carboxyl groups and hydroxyl groups
control the size and morphology. Discrete particles were seen using VA2, attributing to the high
charge of carboxyl groups. The charge density of VA2 is much higher than VA-Mms6 or VA3.
Formation of magnetite nanoparticles was supported by XPS results and the MFM image of
nanoparticles formed in the presence of VA2, further supports the magnetic behavior of the
synthesized particles. MFM images of nanoparticles synthesized in the presence of VA2 shows
that nanoparticles are of size range 40nm. Dynamic light scattering results of particles
synthesized in the presence of VA-Mms6, VA2 and VA3 showed a maximum size distribution at
peak diameters of 88nm, 62nm and 41nm respectively. Owing to the size of nanoparticles from
MFM and DLS, a conclusion can be drawn that they form stable single magnetic domains. The
attempt to make magnetite particles by changing the functional groups in Mms6 into carboxyl
(VA2) was successful. Discrete particles were not visualized using VA-Mms6 and VA3.
Finally, based on the above observations and the experimental results, it is proposed that
carboxyl group‟s peptides have a better control over the size and morphology of magnetite
nanoparticles. The negatively charged surface of VA2 serves as a template for the formation of
magnetite particles with uniform structure and morphology.
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There are several questions that need to be addressed in the near future. First, all the data
regarding the sizes and morphologies of nanoparticles were just qualitative, further quantitative
magnetic property measurements of the synthesized magnetite nanoparticles are required.
Second, the synthesized magnetic particles always tend to aggregate and this behavior can be
understood by studying the structure of Mms6, VA2 and VA3. The structural study will give a
better idea of the structure relationship of Mms6, VA2, and VA3 to the formation of magnetite
nanoparticles. And finally, the measurements of iron binding activities of VA2 should be carried
out as it would help in producing quantitative data regarding the binding constant of iron to VA2.
An attempt was made in this study in synthesizing magnetite particles in presence of peptides
coupled with biocompatible polymer PEG. Further studies should be carried out in characterizing
the particles that are synthesized using PEG. The potential challenge in future would be film
coating synthesized magnetite nanoparticles with a biocompatible and non-toxic polymer like
PEG, dextran or chitosan. Magnetite particles are used as a contrast agent in MRI for better
resolution of human internal structures. Usage of magnetite particles reduces noise signals of
absorbing tissues. Hence the functionalized magnetite particles can be effectively used in
medical applications like MRI.
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Appendix A: Amino Acid Analysis
Mms6
Residue

Conc.
nmol/inj

Mole
%

Expected
Mole %

Abs.
Dev.

Expected # of
Residues

cm-cys

0.065

0.30

Asx

3.952

18.41

Thr

0.244

1.14

Ser

0.897

4.18

4.41

-0.23%

3

Glx

3.620

16.87

17.65

-0.78%

12

Gly

2.577

12.01

11.76

0.24%

8

Ala

2.020

9.41

8.82

0.59%

6

Val

1.480

6.90

5.88

1.01%

4

Met

0.178

0.83

2.94

-2.11%

2

Ile

0.670

3.12

2.94

0.18%

2

Leu

0.949

4.42

2.94

1.48%

2

Tyr

0.153

0.71

0.71%

Phe

0.193

0.90

0.90%

His

2.449

11.41

13.24

-1.82%

9

Lys

0.812

3.78

2.94

0.84%

2

1.204

5.61

5.88

-0.27%

4

Total
Nmol/Inj.:

21.46

0.30%
20.59

-2.18%

14

1.14%

Pro

Cys

TRP
Arg

99.70

68
100.00
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VA2
Expected
Mole%

Abs.
Dev.

Expected
# of
Residues

Residue

Conc.
nmol/inj

Mole
%

cm-cys

0.065

0.30

Asx

3.952

18.41

Thr

0.244

1.14

Ser

0.897

4.18

4.41

-0.23%

3

Glx

3.620

16.87

17.65

-0.78%

12

Gly

2.577

12.01

11.76

0.24%

8

Ala

2.020

9.41

8.82

0.59%

6

Val

1.480

6.90

5.88

1.01%

4

Met

0.178

0.83

2.94

-2.11%

2

Ile

0.670

3.12

2.94

0.18%

2

Leu

0.949

4.42

2.94

1.48%

2

Tyr

0.153

0.71

0.71%

Phe

0.193

0.90

0.90%

His

2.449

11.41

13.24

-1.82%

9

Lys

0.812

3.78

2.94

0.84%

2

1.204

5.61

5.88

-0.27%

4

Total
Nmol/Inj.:

21.46

0.30%
20.59

-2.18%

14

1.14%

Pro

Cys

TRP
Arg

99.70

68
100.00
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Appendix B: XPS Spectra
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XPS spectra of magnetite particles synthesized in the presence of (a) VA-Mms6, (b) VA2, (c)VA3 and (d)
standard magnetite particles
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